Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$634K Hold
4,935
0.15% 104
2026
Q1
$594K Buy
4,935
+84
+2% +$9.7K 0.15% 110
2025
Q4
$511K Hold
4,851
0.14% 117
2025
Q3
$407K Hold
4,851
0.11% 126
2025
Q2
$384K Hold
4,851
0.12% 118
2025
Q1
$435K Sell
4,851
-100
-2% -$9.34K 0.15% 101
2024
Q4
$493K Hold
4,951
0.18% 84
2024
Q3
$562K Hold
4,951
0.21% 78
2024
Q2
$613K Hold
4,951
0.28% 70
2024
Q1
$653K Sell
4,951
-308
-6% -$38K 0.34% 56
2023
Q4
$573K Buy
5,259
+177
+3% +$18.4K 0.39% 62
2023
Q3
$523K Buy
5,082
+57
+1% +$6.14K 0.38% 64
2023
Q2
$580K Buy
5,025
+43
+0.9% +$4.88K 0.45% 54
2023
Q1
$530K Buy
4,982
+63
+1% +$6.8K 0.44% 57
2022
Q4
$546K Buy
+4,919
New +$503K 0.49% 57

Other funds holding MRK

BOS Asset Management's MRK Position: Q2 2026 in Review

BOS Asset Management held its Merck (MRK) position steady in Q2 2026 at 4,935 shares worth $634K. The position accounts for 0.15% of the portfolio, ranked #104.

BOS Asset Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $653K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • BOS Asset Management held 4,935 shares of Merck worth $634K as of Q2 2026.
  • BOS Asset Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.15% of BOS Asset Management's portfolio in Q2 2026, its #104 holding.
  • BOS Asset Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • BOS Asset Management's Merck position peaked at $653K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BOS Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.